CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Spero Therapeutics Inc Company Snapshot
Spero Therapeutics Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Spero Therapeutics Inc with three other companies in this sector in the United States: Revance Therapeutics Inc (2016 sales of $300,000.00 of which 100% was Botulinum Toxin Products), Dicerna Pharmaceuticals Inc ($295,000.00 of which 100% was RNA Interference (RNAi) Therapeutics), and Intra-Cellular Therapies Inc ($330,702.00 of which 100% was Pharmaceutical).

Sales Analysis.
   
   
 
  Stock Performance Chart for Spero Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 12.25
(Figures in U.S. Dollars)
1 Week 5.7%   13 Weeks 13.2%  
4 Weeks n/a   52 Weeks n/a  
 
Spero Therapeutics Inc Key Data:
  Ticker: SPRO Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 335,000
(Year Ending Jan 2017).
Employees: N/A
  Currency: U.S. Dollars Market Cap: 176,022,480
  Fiscal Yr Ends: December Shares Outstanding: 14,369,182
  Share Type: Common Closely Held Shares: 2,878,719
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.